Journal Article

MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms

Barletta, Antonino, Arrigoni, Alberto, Gerevini, Simonetta, Lorini, Ferdinando Luca, Caroli, Anna, Pezzetti, Giulio, Zangari, Rosalia, Napolitano, Angela, Capelli, Serena, Sessa, Maria, Longhi, Luca Giovanni, Remuzzi, Andrea

2023

Overview

Background and objective Despite olfactory disorders being among the most common neurological complications of coronavirus disease 2019 (COVID-19), their pathogenesis has not been fully elucidated yet. Brain MR imaging is a consolidated method for evaluating olfactory system’s morphological modification, but a few quantitative studies have been published so far. The aim of the study was to provide MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms, including olfactory dysfunction. Methods 196 COVID-19 patients (median age: 53 years, 56% females) and 39 controls (median age 55 years, 49% females) were included in this cross-sectional observational study; 78 of the patients reported olfactory loss as the only neurological symptom. MRI processing was performed by ad-hoc semi-automatic processing procedures. Olfactory bulb (OB) volume was measured on T2-weighted MRI based on manual tracing and normalized to the brain volume. Olfactory tract (OT) median signal intensity was quantified on fluid attenuated inversion recovery (FLAIR) sequences, after preliminary intensity normalization. Results COVID-19 patients showed significantly lower left, right and total OB volumes than controls ( p  < 0.05). Age-related OB atrophy was found in the control but not in the patient population. No significant difference was found between patients with olfactory disorders and other neurological symptoms. Several outliers with abnormally high OT FLAIR signal intensity were found in the patient group. Conclusions Brain MRI findings demonstrated OB damage in COVID-19 patients with neurological complications. Future longitudinal studies are needed to clarify the transient or permanent nature of OB atrophy in COVID-19 pathology. Graphical abstract

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Age / Atrophy / Coronaviruses / COVID-19 / COVID-19 - complications / COVID-19 - diagnostic imaging / Cross-Sectional Studies / Female / Humans / Information processing / Magnetic Resonance Imaging / Male / Medicine / Medicine & Public Health / Middle Aged / Neuroimaging / Neurological complications / Neurological diseases / Neurology / Neuroradiology / Neurosciences / Olfaction / Olfaction disorders / Olfaction Disorders - diagnostic imaging / Olfaction Disorders - etiology / Olfactory bulb / Olfactory Bulb - diagnostic imaging / Olfactory system / Original Communication / Patients / Smell